Third Annual Dengue Endgame Summit
REGISTER

Speakers

Stephanie Moquin, PhD

Stephanie Moquin, PhD

Emeryville, CA, USA

Principal Scientist II

Novartis, USA

Stephanie Moquin is a Principal Scientist II at Novartis in the Global Health department of Biomedical Research, where she has worked on the discovery and development of a dengue NS4B inhibitor and a coronavirus Mpro inhibitor, which have both completed Phase I clinical trials. Dr. Moquin obtained her PhD in Biomedical Sciences from UCSF, where she studied genomic interactions of the Epstein-Barr virus.

August 12-14, 2025

KG Tan Auditorium, National Veterans Resource Center – Syracuse, NY
Presented by The Global Health Institute at SUNY Upstate Medical University

Thank You Sponsors